Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
9,105.20
8,849.56
8,649.11
7,834.85
6,680.71
6,290.78
6,137.38
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
9,105.20
8,849.56
8,649.11
7,834.85
6,680.71
6,290.78
6,137.38
Raw Material Cost
7,118.41
6,409.23
6,463.18
5,855.80
4,771.03
4,289.06
4,380.83
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
656.08
606.77
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
45.93
48.70
61.65
69.30
72.93
68.37
70.12
Selling and Distribution Expenses
986.87
1,340.79
1,191.66
1,035.02
1,007.40
1,202.56
1,059.13
Other Expenses
38.08
41.46
34.03
34.21
-39.38
-40.82
15.13
Total Expenditure (Excl Depreciation)
8,531.97
8,213.28
8,056.80
7,302.24
6,113.68
5,758.54
5,661.42
Operating Profit (PBDIT) excl Other Income
573.2
636.3000000000001
592.3
532.6
567
532.2
476
Other Income
71.84
75.83
67.93
85.76
22.55
63.33
57.79
Operating Profit (PBDIT)
1,216.07
1,216.93
1,182.07
1,109.86
972.34
890.63
848.93
Interest
45.93
48.70
61.65
69.30
72.93
68.37
70.12
Exceptional Items
-0.08
-6.30
0.00
0.00
0.00
-3.01
-22.70
Gross Profit (PBDT)
1,986.79
2,440.33
2,185.93
1,979.05
1,909.67
2,001.72
1,756.55
Depreciation
591.63
574.88
572.32
531.57
433.52
384.12
362.48
Profit Before Tax
578.43
587.05
548.10
508.99
465.90
435.14
393.63
Tax
50.89
29.37
53.10
71.30
72.51
66.08
61.47
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
509.61
548.64
478.02
420.07
365.04
340.14
302.41
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
509.61
548.64
478.02
420.07
365.04
340.14
302.41
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
18.10
10.60
17.50
16.30
25.01
26.25
29.74
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
527.71
559.25
495.51
436.38
390.05
366.39
332.15
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.06
1.1
1.12
1.22
1.19
0.0
0.0
Reserves
5,312.11
5,012.99
4,632.73
4,242.21
3,822.26
3,321.14
3,073.79
Earnings per share (EPS)
0.74
0.8
0.71
0.67
0.59
0.55
0.49
Diluted Earnings per share
0.74
0.8
0.71
0.67
0.59
0.55
0.49
Operating Profit Margin (Excl OI)
6.07%
6.4%
6.26%
6.29%
7.73%
7.04%
6.98%
Gross Profit Margin
12.85%
13.13%
12.95%
13.28%
13.46%
13.02%
12.32%
PAT Margin
5.6%
6.2%
5.53%
5.36%
5.46%
5.41%
4.93%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 2.89% vs 2.32% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is -5.63% vs 12.86% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 0.27% vs 2.42% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -5.75% vs -20.94% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of Shandong Xinhua Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
9,105.20
700.71
8,404.49
1,199.42%
Other Operating Income
0.00
0.00
0.00
Total Operating income
9,105.20
700.71
8,404.49
1,199.42%
Raw Material Cost
7,118.41
52.18
7,066.23
13,542.03%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
206.28
-206.28
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
45.93
30.31
15.62
51.53%
Selling and Distribution Expenses
986.87
158.09
828.78
524.25%
Other Expenses
38.08
8.69
29.39
338.20%
Total Expenditure (Excl Depreciation)
8,531.97
533.76
7,998.21
1,498.47%
Operating Profit (PBDIT) excl Other Income
573.23
166.94
406.29
243.37%
Other Income
71.84
44.91
26.93
59.96%
Operating Profit (PBDIT)
1,216.07
248.11
967.96
390.13%
Interest
45.93
30.31
15.62
51.53%
Exceptional Items
-0.08
-3.96
3.88
97.98%
Gross Profit (PBDT)
1,986.79
648.53
1,338.26
206.35%
Depreciation
591.63
36.26
555.37
1,531.63%
Profit Before Tax
578.43
177.58
400.85
225.73%
Tax
50.89
-0.63
51.52
8,177.78%
Provisions and contingencies
0
0
0.00
Profit After Tax
509.61
178.48
331.13
185.53%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
509.61
178.48
331.13
185.53%
Share in Profit of Associates
0
0
0.00
Minority Interest
18.10
-0.27
18.37
6,803.70%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
527.71
178.21
349.50
196.12%
Equity Capital
0
0
0.00
Face Value
1.06
0.00
0.00
Reserves
5,312.11
936.93
4,375.18
466.97%
Earnings per share (EPS)
0.74
0.24
0.50
208.33%
Diluted Earnings per share
0.74
0.24
0.50
208.33%
Operating Profit Margin (Excl OI)
6.07%
23.83%
0.00
-17.76%
Gross Profit Margin
12.85%
30.52%
0.00
-17.67%
PAT Margin
5.60%
25.47%
0.00
-19.87%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 910.52 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 2.89% vs 2.32% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 52.77 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -5.63% vs 12.86% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 114.42 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 0.27% vs 2.42% in Dec 2023
Annual - Interest
Interest 4.59 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -5.75% vs -20.94% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.07%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
